Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. - Jain P; Kanagal-Shamanna R; Zhang S; Ok CY; Navsaria L; Nastoupil L; Lee HJ; Tang G; Yin CC; Badillo M; Nair R; Li S; et al. (American journal of hematology, 2021)